These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 27518913)
1. Role of CFTR variants explored in developing cystic fibrosis symptoms: Latest research highlights disease manifestations in diverse ethnicities of children. Am J Med Genet A; 2016 Sep; 170(9):2233-4. PubMed ID: 27518913 [No Abstract] [Full Text] [Related]
2. Frequency of intron 8 CFTR polythymidine sequence variant in neonatal blood specimens. Chin S; Ranieri E; Gerace RL; Nelson PV; Carey WF Lancet; 1997 Nov; 350(9088):1368-9. PubMed ID: 9365460 [No Abstract] [Full Text] [Related]
3. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California. Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204 [TBL] [Abstract][Full Text] [Related]
4. Refining the continuum of CFTR-associated disorders in the era of newborn screening. Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754 [TBL] [Abstract][Full Text] [Related]
6. Laboratory tests for the diagnosis of cystic fibrosis. Wang L; Freedman SD Am J Clin Pathol; 2002 Jun; 117 Suppl():S109-15. PubMed ID: 14569807 [TBL] [Abstract][Full Text] [Related]
7. Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants. Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M J Cyst Fibros; 2015 Nov; 14(6):714-9. PubMed ID: 25824995 [TBL] [Abstract][Full Text] [Related]
8. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses. Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809 [TBL] [Abstract][Full Text] [Related]
9. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System. Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357 [TBL] [Abstract][Full Text] [Related]
10. Cystic Fibrosis Diagnosis and Newborn Screening. Rosenfeld M; Sontag MK; Ren CL Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178 [TBL] [Abstract][Full Text] [Related]
18. Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis. Padoan R; Genoni S; Moretti E; Seia M; Giunta A; Corbetta C Acta Paediatr; 2002; 91(1):82-7. PubMed ID: 11883825 [TBL] [Abstract][Full Text] [Related]
19. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations. Mickle JE; Cutting GR Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548 [TBL] [Abstract][Full Text] [Related]
20. An innovative strategy for personalised medicine in a CFSPID case that evolved with time. Twynam-Perkins J; Fall A; Lefferts JW; Urquhart DS Paediatr Respir Rev; 2023 Sep; 47():23-26. PubMed ID: 37407313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]